Speaker illustration

Ms Sabine Denissen

Erasmus Medical Center, Rotterdam (Netherlands (The))

Impact of a cardiovascular disease screening result on prevention-seeking behavior and compliance with preventive treatment in asymptomatic ROBINSCA participants

Event: EuroPrevent 2019

Topic: Cardiovascular Risk Assessment

Session: Risk Factors and Prevention – Cardiovascular Risk Assessment

Thumbnail

Prevalence of coronary artery calcium by sex, age and socio-economic status in the ROBINSCA trial

Event: EuroPrevent 2019

Topic: Imaging

Session: Rapid Fire Session 1

Thumbnail

Contamination rate in the risk or benefit in screening for cardiovascular disease (ROBINSCA)-trial

Event: EuroPrevent 2018

Topic: Cardiovascular Risk Assessment

Session: Risk Factors and Prevention – Cardiovascular Risk Assessment

Thumbnail

This platform is supported by

logo Novo Nordisk